The Ins and Outs of Glaucoma Treatment in 2020: MIGS, Lasers, Drops and Depot | ASCRS
CME Activity
The Ins and Outs of Glaucoma Treatment in 2020: MIGS, Lasers, Drops and Depot
August 2020

CME Activity Details

Activity Availability

This CME activity is available free of charge to all ophthalmologists. Click the button below to access this activity in the CME 24/7 portal. 

Begin Activity Now

This activity is supported by unrestricted educational grants from Allergan, Glaukos Corporation, Mati Therapeutics, Inc, and Santen Pharmaceutical.

Description

It is imperative to review all glaucoma treatment options in order to deliver better surgical outcomes and slow progression.

In this 1 hour CME activity based off of a live webinar held on August 19, 2020, faculty will review glaucoma treatment strategies at different stages of disease, including integration of different treatment modalities, planning for possible future interventions and treatment of side effects and complication. View the detailed activity agenda listed below for presentation titles and speaker names.

CME Information

Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credits™.
Activity Expiration Date: August 31, 2021

Learning Objectives

Upon successful completion of this activity, participants should be able to:

  • Examine limitations of current eyedrop therapy and elucidate how laser, MIGS and sustained delivery address the unmet need created by problems with eyedrop therapy.
  • Explain recent data on selective laser trabeculoplasty that support a role for laser early in the treatment paradigm.
  • Describe the current available MIGS surgical options, including those that address the trabecular meshwork, the canal of Schlemm, and the subconjunctival outflow pathway.
  • Recognize tips and surgical pearls for delivering excellent outcomes using MIGS with cataract surgery for glaucoma patients.
  • Discuss glaucoma treatment strategies at different stages of disease, including integration of different treatment modalities, planning for possible future interventions and treatment side effect and complication considerations.
Detailed Activity Agenda
Welcome and ARS Questions

Cathleen McCabe, MD and Nathan Radcliffe, MD

Discussion of Treatment Options

Inder Paul Singh, MD

Inder Paul Singh MD Headshot
Interventional Glaucoma

Ike Ahmed, MD 

MIGS and the Cataract Surgeon

Manjool Shah, MD

Mapping Out Glaucoma Management
Cathleen McCabe, MD and Nathan Radcliffe, MD

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.